LOS ANGELES, March 29, 2018 -- US based company Earth Healthcare offers a new Cannabis DNA Test Kit. Earth Healthcare's patent-pending Cannabis test kit, CANNA DNA Test Kit allows Earth Healthcare labs to analyze your genetic markers to determine your body's natural inclination to accept cannabinoids as medicine - whether the cannabinoids are produced endogenously, from plants or synthetically. This approach takes the guesswork out of medical cannabis use, offering you personalized treatment options that will optimize efficacy and minimize unintended effects.
|
|||||
We all have a different DNA makeup; our DNA proves it. That is why our body processes everything its own individual way, including cannabis. Would you like to know what your DNA says about how your body will react when you use cannabis?
Cannabinoids are such a useful and unique medicine to help restore homeostasis in the body because it is cannabinoids that are naturally produced in the body (endogenously) that we rely on for homeostasis. As a result, many imbalances and ailments can be restored from the use of exogenous cannabinoids, produced outside the body.
With the rise in medical cannabis use for a variety of medical conditions including cancer, autoimmune disorders, and dietary issues, Earth Healthcare's CANNA DNA genetic test kit will allow people to know how their body will react to it. This approach will take the guesswork out of cannabis use, offering personalized treatment recommendations that optimize efficacy and minimize unintended effects.
CANNA DNA Test Kit can target symptom relief, and the results can be customized for patients with symptom-relief recommendations specifically in the areas of Anxiety, Appetite, Stress, Insomnia, Nausea, and Pain.
Earth Healthcare's kits are available online at EarthHealthcare.com, dispensaries, and physicians offices. The kits include; sample-collection swabs, instructions, and a pre-addressed, stamped envelope. The samples are mailed to Earth Healthcare's CLIA-accredited and CAP-certified partner laboratory, where they analyze your DNA and compile a customized report. The report includes a cannabis-specific genomic profile, identifying how your body metabolizes Delta-9 tetrahydrocannabinol (THC) and cannabidiol (CBD), and recommendations of cannabis varieties best suited to your body chemistry and specific needs.
Scientific research continues to validate its efficacy for an expanding spectrum of illnesses and conditions. Yet, doctors have been limited to recommending cannabis without having supportive data to allow them to prescribe the medicine safely and effectively, until now.
Visit Earth Healthcare's Website to get more information or to order a kit at: www.earthhealthcare.com
Company: Earth Healthcare
Media Contact: Nicole Lenz
Los Angeles, CA
[email protected]
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/92addbb0-047c-4121-9e13-31f0f70c1b84


Siemens Energy Q3 Profit Beats Forecast as AI-Driven Power Demand Fuels Growth
Telegram Restored on Apple App Store After Temporary Removal
UK AI Security Tests Reveal Anthropic and OpenAI Agents Attempted Unauthorized Actions
SpaceX Earnings Preview: Bernstein Says 4 Key Factors Will Drive Long-Term Valuation
Meta Cuts Wipro Outsourcing by 25% After AI-Led Restructuring
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
BHP Port Hedland Strike Set to Proceed as Wage Talks Continue
Boeing Stock Jumps as FAA Certifies 737 MAX-7 After Years of Regulatory Review
Shein Targets $30B-$40B Valuation in Hong Kong IPO Planned for August
DHL Q2 Profit Jumps 24% as Express Business Drives Growth
BYD July Global Vehicle Sales Rise 22% as Overseas Demand Surges
Vast Eyes Hong Kong IPO as Chinese AI Unicorn Gains Momentum
Heineken H1 Operating Profit Meets Forecast as Beer Volumes Beat Expectations
Alibaba Stock Jumps as Qwen 3.8-MAX AI Model Intensifies China's AI Race
Infineon Raises 2026 Revenue Outlook as AI Data Center Demand Fuels Record Quarterly Sales
Bayer Q2 Earnings Beat Forecasts as Crop Science Boosts Results, Debt Outlook Improves
Samsung, SK Hynix Test AMEC Chipmaking Tools for China Backup Plan 



